Who should receive an implantable cardioverter-defibrillator after myocardial infarction?

Current Heart Failure Reports
Stavros Mountantonakis, Mathew D Hutchinson

Abstract

Despite a decline in overall cardiovascular mortality, the incidence of sudden cardiac death (SCD) continues to rise. Patients who survive a myocardial infarction (MI) with depressed ejection fraction are at particularly high risk for SCD. The development of implantable cardioverter-defibrillators (ICDs) has revolutionized SCD prevention; however, despite the current fervor for device implantation, many unresolved questions remain about risk stratification in post-MI patients. This review presents the current indications and timing of ICD implantation for primary and secondary prevention of SCD after MI. Several conventional and investigational methods of risk stratification after MI, as well as current controversies regarding device implantation in specific patient populations, are also reviewed.

References

Aug 1, 1994·Journal of Cardiovascular Electrophysiology·D J StattersA J Camm
Dec 15, 1993·Annals of Internal Medicine·R J MyerburgA Castellanos
Nov 15, 1997·Journal of the American College of Cardiology·J J de Vreede-SwagemakersH J Wellens
Dec 31, 1997·The New England Journal of Medicine·UNKNOWN Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
Sep 19, 2000·Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology·P Della Bella
Feb 24, 2001·Circulation·M H RaittUNKNOWN Antiarrhythmics Versus Implantable Defibrillators investigators
Dec 12, 2001·Journal of the American College of Cardiology·J J BaileyM Hodges
Mar 22, 2002·The New England Journal of Medicine·Arthur J MossUNKNOWN Multicenter Automatic Defibrillator Implantation Trial II Investigators
May 21, 2004·The New England Journal of Medicine·Michael R BristowUNKNOWN Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators
May 21, 2004·The New England Journal of Medicine·Alan KadishUNKNOWN Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators
Nov 19, 2004·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Abdul WasePeter A McCullough
Dec 14, 2004·The New England Journal of Medicine·Stefan H HohnloserUNKNOWN DINAMIT Investigators
Jan 22, 2005·The New England Journal of Medicine·Gust H BardyUNKNOWN Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators
Apr 6, 2005·Journal of the American College of Cardiology·David BelloJeffrey J Goldberger
Jun 24, 2005·The New England Journal of Medicine·Scott D SolomonUNKNOWN Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators
Jul 5, 2005·Journal of the American College of Cardiology·Anil K GehiJ Anthony Gomes
Jul 19, 2005·Journal of the American College of Cardiology·Alfred E BuxtonUNKNOWN PainFREE Rx II Investigators
Oct 7, 2005·The New England Journal of Medicine·Gillian D SandersDouglas K Owens
Jul 10, 2007·Journal of the American College of Cardiology·Daniel J CantillonSei Iwai
Sep 18, 2007·Journal of the American College of Cardiology·Alfred E BuxtonUNKNOWN MUSTT Investigators
Jan 22, 2008·Journal of the American College of Cardiology·Ilan GoldenbergUNKNOWN MADIT-II Investigators
Feb 7, 2009·Journal of the American College of Cardiology·Otto CostantiniUNKNOWN ABCD Trial Investigators

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.